A gene expression signature predicts survival of patients with stage I non-small cell lung cancer.

A gene expression signature predicts survival of patients with stage I non-small cell lung cancer.

Lung cancer is the leading cause of cancer-related death in the United States. Nearly 50% of patients with stages I and II non-small cell lung cancer (NSCLC) will die from recurrent disease despite surgical resection. No reliable clinical or molecular predictors are currently available for identifyi...

Full description

Bibliographic Details
Main Authors: Yan Lu, William Lemon, Peng-Yuan Liu, Yijun Yi, Carl Morrison, Ping Yang, Zhifu Sun, Janos Szoke, William L Gerald, Mark Watson, Ramaswamy Govindan, Ming You
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2006-12-01
Series:PLoS Medicine
Online Access:http://europepmc.org/articles/PMC1716187?pdf=render

Internet

http://europepmc.org/articles/PMC1716187?pdf=render

Similar Items